Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · IEX Real-Time Price · USD
7.70
+0.12 (1.58%)
Apr 26, 2024, 4:00 PM EDT - Market closed

MRVI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021202020192018
Market Capitalization
1,0191,6463,65210,7987,232--
Market Cap Growth
--54.93%-66.18%49.29%---
Enterprise Value
1,0001,6283,54710,7777,587366318
PE Ratio
-13.83-13.8316.5959.3281.29--
PS Ratio
3.535.704.1413.5125.46--
PB Ratio
2.443.956.7034.2281.71--
P/FCF Ratio
13.8522.387.2130.4844.84--
P/OCF Ratio
8.0713.046.8129.3047.52--
EV/Sales Ratio
3.465.634.0213.4826.712.552.57
EV/EBITDA Ratio
1.372.2210.4535.0651.127.476.96
EV/EBIT Ratio
1.462.3811.7739.3661.8914.7213.62
EV/FCF Ratio
13.6122.137.0030.4247.0452.46-83.76
Debt / Equity Ratio
1.341.340.971.686.672.762.35
Debt / EBITDA Ratio
0.760.761.551.733.987.987.44
Debt / FCF Ratio
7.577.571.041.503.6656.01-89.52
Quick Ratio
7.207.207.007.132.201.451.05
Current Ratio
8.008.007.707.892.542.051.50
Asset Turnover
0.140.140.400.470.310.26-
Interest Coverage
14.8814.8814.779.053.990.830.85
Return on Equity (ROE)
-24.10%-24.10%46.70%78.70%77.40%-3.10%-
Return on Assets (ROA)
-5.70%-5.70%10.10%10.80%9.60%-0.80%-
Return on Capital (ROIC)
0.67%0.67%41.38%49.00%17.10%4.57%3.59%
Earnings Yield
-11.68%-7.23%6.03%1.69%1.23%--
FCF Yield
7.22%4.47%13.87%3.28%2.23%--
Buyback Yield / Dilution
48.33%48.33%0.96%-791.81%88.62%-0.00%-
Total Shareholder Return
48.33%48.33%0.96%-791.81%88.62%-0.00%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).